P S Lietman, R Saral. Show Affiliations »
Abstract
Entities: Disease Species
Mesh： See more » Acyclovir/adverse effectsAcyclovir/therapeutic useChickenpox/drug therapyChickenpox/prevention & controlChickenpox/therapyClinical Trials as TopicCytomegalovirus Infections/drug therapyCytomegalovirus Infections/prevention & controlCytomegalovirus Infections/therapyDouble-Blind MethodHerpes Simplex/drug therapyHerpes Simplex/prevention & controlHerpes Simplex/therapyHerpes Zoster/drug therapyHerpes Zoster/therapyHerpesviridae Infections/drug therapyHerpesviridae Infections/immunologyHerpesviridae Infections/prevention & controlHerpesviridae Infections/therapyHerpesvirus 4, HumanHumansImmune ToleranceInterferon Type I/adverse effectsInterferon Type I/therapeutic useRecurrenceVidarabine/adverse effectsVidarabine/therapeutic use
Substances： See more » Interferon Type IVidarabineAcyclovir
Year: 1985 PMID： 3002259 DOI： 10.1016/s0166-3542(85)80034-6
Source DB: PubMed Journal: Antiviral Res ISSN： 0166-3542 Impact factor: 5.970